期刊文献+

碘-125籽源组织间照射患者和周围人员受照剂量的测量和估算 被引量:4

Estimation and Measurement of Exposure Doses to the Circumstance and Patients after Iodine-125 Seeds Permanent Interstitial Implanting.
下载PDF
导出
摘要 目的 测量碘 -12 5籽源植入人体模型后患者和周围人员的受照剂量。方法 模拟前列腺癌治疗 ,用FD310 1γ剂量仪测量体表、离体表 30cm和 10 0cm处的外照射剂量率 ,用LiFTLD探测器测量体模内各主要器官的剂量当量。结果 患者体表剂量与各主要器官剂量当量都较低。结论 碘 -12 5籽源组织间放射治疗对患者和周围人员都是一种较安全的肿瘤治疗方法。 Objective To measure the exposure doses to the personel after implanting Iodine-125 seeds into the simulated human-body,phantom.Methods The exposure dose rates were detected by FD3101 gamma-dosimeter at the phantom surface and the locations at 30 cm and 100 cm from the phantom,respectively.Extensive dose equvalent measurements were performed at various organ locations in the phantom,using TLD dosimeters.Results All results were listed in table 1and table 2.Conclusion Exposure doses have been measured and calculated after Iodine-125 seeds implant.They are much lower than those presented in national standards.it is believed that Iodine-125 seeds permanent interstitial implant is promising radiotherapeatic application.
出处 《中国辐射卫生》 2001年第4期196-197,共2页 Chinese Journal of Radiological Health
基金 上海市科技发展基金资助项目 (9941 1 90 0 2 0 )
关键词 碘-125籽源 剂量 测量估算 Iodine-125 Seed Exposure Dose Estimation and Measurement
  • 相关文献

同被引文献30

  • 1苏鲁,梁武,潘洪珍,徐艺华,洪梅燕,赖雪珍,陈芳.碘-125粒子支架治疗晚期食管癌的疗效研究[J].中华消化内镜杂志,2004,21(5):316-319. 被引量:19
  • 2黄振国,张雪哲,王武,洛小林,王继英.CT导引下^(125)I粒子植入在治疗恶性肿瘤中的应用[J].中华放射学杂志,2004,38(9):921-925. 被引量:135
  • 3文黎明,王洪洲,黄春,陈先菊,蒋涛,陈晓辉,何利.自制碘-125支架治疗进展期食管癌的临床应用研究[J].川北医学院学报,2006,21(5):416-419. 被引量:5
  • 4尹佰元.临床核素治疗学[M].北京:人民军医出版社,2003.169-180.
  • 5Ling CC.Permanent implants using Au-198,Pd-103 and I-125:radiobiological considerations based on the linear quadratic model.Int J Radiat Oncol Biol Phys,1992,23(1):81-87.
  • 6Grimm PD,Blasko JC,Sylvester JE,et al.10-year biochemical(prostate-specific antigen) control of prostate cancer with (125)Ibrachytherapy.Int J Radiat Oncol Biol Phys,2001,51(1):31-40.
  • 7Beyer DC,Puente F,Rogers KL,et al.Prostate brachytherapy:comparison of dose distribution with different 125I source designs.Radiology,2001,221(3):623-627.
  • 8Raben A,Mychalczak B.Brachytherapy for non-small cell lung cancer and selected neoplasms of the chest.Chest,1997,112 (4Suppl):276S-286S.
  • 9Chen Y,Stanton RE,Holst RJ,et al.Treatment planning for prostate implant with loose seeds.MedPhys,1997,24(7):1141-1145.
  • 10Chen A,Galloway M,Landreneau R,et al.Intraoperative 125I brachytherapy for high-risk stage Ⅰ non-small cell lung carcinoma.Int J Radiat Oncol Biol Phys,1999,44(5):1057-1063.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部